.Pfizer Vice President, Late Stage Clinical Development in Bothell, United States ROLE SUMMARY :Pfizer Oncology has an industry-leading portfolio of 25 approved innovative cancer medicines, including major therapies for metastatic breast cancer, prostate cancer, urothelial carcinoma, and haemato-oncological malignancies. Pfizer's in-line portfolio is focused on four broad, key areas: breast cancer, genitourinary cancer, hematology, and precision medicine, complemented by an extensive pipeline of over 50 programs in clinical development.The Oncology Late-Stage Breast Cancer Therapeutic Area (TA) Head will report to the Chief Development Officer for Oncology and oversee the development and execution of comprehensive late-stage clinical development strategies for Pfizer-oncology assets in Breast Cancer. This role will collaborate cross-functionally across Pfizer Oncology to define and oversee execution of integrated development strategies. The Late-Stage Breast Cancer TA Head will build, engage, and retain a team of drug development experts with deep expertise in oncology.The position has direct impact on the Pfizer Oncology portfolio and requires an exceptional leader in oncology drug development with a thorough understanding of end-to-end development, therapeutic area expertise, an understanding of related products, the external landscape, and the executive leadership capabilities needed to realize the potential of the portfolio and deliver medicines to patients. This is a highly visible, critical position which requires strategic thinking, leadership and exceptional communication skills with the ability to work with external partners and potential business development partners. May participate in and lead business development efforts as assigned.ROLE RESPONSIBILITIES:Major responsibilities include but are not limited to:Provide executive leadership of late-stage development programs for designated therapeutic area across Pfizer Oncology governance committees, as well as clinical development partnerships and collaborations.As the senior drug development expert for their assigned therapeutic area, the incumbent will drive innovative drug development strategies and plans in their portfolio by leveraging deep expertise and insights from key stakeholders and team members.Apply oncology drug development and disease-area knowledge to ensure that the programs are managed in an efficient and rigorous manner as reflected in the design, conduct, and prioritization of initial and lifecycle indications with a high likelihood of clinical, regulatory, and commercial success.Ensure continuity in development plans and identify gaps to be addressed through clinical development. Enable effective decision making based upon objective clinical safety and efficacy response measures.Actively monitor progress of all studies and maintain alignment to strategic objectives for therapeutic area and broader oncology portfolio #J-18808-Ljbffr
